Acute double-blind comparison of olanzapine and haloperidol in schizophrenia patients age ≥60.

被引:0
|
作者
Gilmore, J
McGuire, G
Kennedy, JS
Shaw, SC
Kaiser, CJ
Sutton, V
Street, J
Kinon, BJ
Tollefson, G
Breier, A
Lilly, E
机构
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Univ Calif Irvine, Orange, CA 92668 USA
来源
关键词
D O I
暂无
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
引用
收藏
页码:100 / 100
页数:1
相关论文
共 50 条
  • [1] A DOUBLE-BLIND COMPARISON OF RACLOPRIDE AND HALOPERIDOL IN THE ACUTE PHASE OF SCHIZOPHRENIA
    HIRSCH, SR
    BARNES, TRE
    DICKINSON, M
    FERNANDEZ, M
    JOLLEY, A
    PUSAVAT, L
    RICCIO, M
    SPELLER, J
    MCCREADIE, RG
    STEWART, M
    STANDISHBARRY, H
    GOPPINATH, HV
    METCALFE, M
    SONI, S
    DAVIDSON, P
    COOKSON, J
    SILVERSTONE, T
    MALLETT, P
    DINAN, TG
    CHANAS, A
    UPPFELDT, G
    MATHIE, B
    ACTA PSYCHIATRICA SCANDINAVICA, 1992, 86 (05) : 391 - 398
  • [2] REMOXIPRIDE AND HALOPERIDOL IN THE ACUTE PHASE OF SCHIZOPHRENIA - A DOUBLE-BLIND COMPARISON
    DEO, R
    SONI, S
    RASTOGI, SC
    LEVINE, S
    PLANT, I
    EDWARDS, JG
    MITCHELL, M
    CHANAS, A
    ACTA PSYCHIATRICA SCANDINAVICA, 1990, 82 : 120 - 124
  • [3] A one-year double-blind comparison of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in patients with schizophrenia
    Breier, A
    Keefe, RS
    Young, CA
    Purdon, SE
    Gold, JM
    Davis, KL
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 274 - 275
  • [4] A Double-Blind, Randomized Comparison Study of Efficacy and Safety of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With Schizophrenia and Acute Agitated Behavior
    Chan, Hung-Yu
    Ree, Shao-Chun
    Su, Lien-Wen
    Chen, Jiann-Jyh
    Chou, Sun-Yuan
    Chen, Chih-Ken
    Chen, Ying-Sheue
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (03) : 355 - 358
  • [5] Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia
    Wright, P
    Birkett, M
    David, SR
    Meehan, K
    Ferchland, I
    Alaka, KJ
    Saunders, JC
    Krueger, J
    Bradley, P
    San, L
    Bernardo, M
    Reinstein, M
    Breier, A
    AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (07): : 1149 - 1151
  • [6] Cholesterol and cognition in schizophrenia: A double-blind study of patients randomized to clozapine, olanzapine and haloperidol
    Krakowski, Menahem
    Czobor, Pal
    SCHIZOPHRENIA RESEARCH, 2011, 130 (1-3) : 27 - 33
  • [7] Double-blind comparison of quetiapine and haloperidol on cognitive functioning in patients with schizophrenia
    Tapp, A
    Wood, AE
    Kilzieh, N
    Kennedy, A
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 379 - 379
  • [8] Olanzapine versus haloperidol in the treatment of patients with chronic schizophrenia: Results of the Japan multicenter, double-blind olanzapine trial
    Ishigooka, J
    Inada, T
    Miura, S
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2001, 55 (04) : 403 - 414
  • [9] DOUBLE-BLIND COMPARISON BETWEEN LOXAPINE AND HALOPERIDOL BY PARENTERAL ROUTE IN ACUTE SCHIZOPHRENIA
    PAPROCKI, J
    VERSIANI, M
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1977, 21 (01): : 80 - 100
  • [10] Olanzapine versus haloperidol: Acute phase results of the international double-blind olanzapine trial
    Beasley, CM
    Hamilton, SH
    Crawford, AM
    Dellva, MA
    Tollefson, GD
    Tran, PV
    Blin, O
    Beuzen, JN
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1997, 7 (02) : 125 - 137